Profarma (B3: PFRM3) stock: the official figures
Profarma (Profarma Distrib Prod Farmaceuticos S.A.) is listed on B3, the São Paulo stock exchange, under the ticker PFRM3. In fiscal 2025 it reported revenue of BRL 11,451m and a net profit of BRL 118.9m, according to the annual accounts it filed with the regulator.
Identifiers for Profarma: CNPJ 45.453.214/0001-51.
Fiscal 2025 figures
| Item | 2025 | 2024 | Change |
|---|---|---|---|
| Revenue | BRL 11,451m | BRL 10,154m | +12.8% |
| Operating profit | BRL 350.0m | BRL 299.7m | +16.8% |
| Net profit | BRL 118.9m | BRL 114.6m | +3.8% |
| Operating margin | 3.1% | 3.0% | +0.1 pts |
| Net margin | 1.0% | 1.1% | −0.1 pts |
| Total assets | BRL 6,234m | BRL 5,616m | +11.0% |
| Equity | BRL 1,346m | BRL 1,303m | +3.3% |
| Cash | BRL 235.1m | BRL 229.6m | +2.4% |
| Operating cash flow | BRL 459.7m | BRL 497.1m | −7.5% |
Margins are calculated from the filed figures: operating profit and net profit over revenue.
10 fiscal years
| Fiscal year | Revenue | Operating profit | Net profit | Document |
|---|---|---|---|---|
| 2025 | BRL 11,451m | BRL 350.0m | BRL 118.9m | Annual report |
| 2024 | BRL 10,154m | BRL 299.7m | BRL 114.6m | Annual report |
| 2023 | BRL 8,662m | BRL 261.1m | BRL 70.4m | Annual report |
| 2022 | BRL 7,816m | BRL 242.9m | BRL 80.9m | Annual report |
| 2021 | BRL 6,413m | BRL 130.7m | BRL 78.2m | Annual report |
| 2020 | BRL 5,481m | BRL 120.6m | BRL 52.3m | Annual report |
| 2019 | BRL 4,801m | BRL 60.9m | BRL 12.0m | Annual report |
| 2018 | BRL 4,271m | BRL 54.9m | −BRL 9.7m | Annual report |
| 2017 | BRL 4,101m | −BRL 11.3m | −BRL 112.7m | Annual report |
| 2016 | BRL 4,085m | BRL 76.2m | −BRL 49.0m | Annual report |
The full income statement, balance sheet and cash flow statement are in the annual accounts of Profarma. Year by year: revenue, net income and dividends paid.
Dividends
In fiscal 2025, Profarma paid BRL 76.7m in dividends, 64.5% of its net profit, according to its cash flow statement.
| Fiscal year | Dividends paid | Share of net profit |
|---|---|---|
| 2025 | BRL 76.7m | 64.5% |
| 2024 | BRL 54.6m | 47.6% |
| 2023 | BRL 31.2m | 44.4% |
| 2021 | BRL 29.1m | 37.2% |
Cash paid out as dividends during the fiscal year, including dividends to minority shareholders of subsidiaries when the company does not report them separately. It is not the dividend per share.
Frequently asked questions about Profarma
- How much did Profarma earn in fiscal 2025?
- Profarma reported a net profit of BRL 118.9m for fiscal 2025, on revenue of BRL 11,451m. The year before it reported a net profit of BRL 114.6m.
- Does Profarma pay a dividend?
- In fiscal 2025, Profarma paid BRL 76.7m in dividends, 64.5% of its net profit, according to its cash flow statement.
- Where is Profarma listed?
- Profarma is listed on B3, the São Paulo stock exchange, under the ticker PFRM3.
- Where do the figures for Profarma come from?
- From the annual financial statements (DFP) that Profarma files with the CVM, the Brazilian securities regulator. Each fiscal year links to its filing.
Where each figure comes from
The annual accounts come from the annual financial statements (DFP) that Profarma files with the CVM, the Brazilian securities regulator. Each fiscal year in the table links to its filing. Celsmar reads the tagged figures from the document and does not adjust them: if an item is not in the filing, it is not shown. More detail in data sources and, if you spot an error, in corrections. What Celsmar is and what it costs, in its fact sheet.
More companies from Brazil and the rest of the region: Latin American stocks.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.